A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma Surgery - 13/09/24
, Michelle E. Tarver 3, Malvina Eydelman 3, George L. Spaeth 4, David W. Parke 5, Kuldev Singh 6On Behalf of the
Glaucoma Outcomes Survey Collaborative Study Group
Résumé |
Purpose |
To develop a patient-reported outcome measure to assess the impact of glaucoma and treatment, including minimally invasive glaucoma surgery (MIGS).
Design |
Observational study before and after concomitant cataract and Food and Drug Administration-approved implantable MIGS device surgery.
Setting |
Survey administration was on a computer, iPad, or similar device.
Patient Population |
184 adults completed the baseline survey, 124 a survey 3 months after surgery, and 106 the 1-month test-retest reliability survey. The age range was 37 to 89 (average age = 72). Most were female (57%), non-Hispanic White (81%), and had a college degree (56%).
Main Outcome Measures |
The Glaucoma Outcomes Survey (GOS) assesses functional limitations (27 items), vision-related symptoms (7 items), psychosocial issues (7 items), and satisfaction with microinvasive glaucoma surgery (1 item). These multiple-item scales were scored on a 0 to 100 range, with a higher score indicating worse health.
Results |
Internal consistency reliability estimates ranged from 0.75 to 0.93, and 1-month test-retest intraclass correlations ranged from 0.83 to 0.92 for the GOS scales. Product-moment correlations among the scales ranged from 0.56 to 0.60. Improvement in visual acuity in the study eye from baseline to the 3-month follow-up was significantly related to improvements in GOS functional limitations (r = 0.18, P = .0485), vision-related symptoms (r = 0.19, P = .0386), and psychosocial concerns (r = 0.18, P = .0503). Responders to treatment ranged from 17% for vision-related symptoms to 48% for functional limitations.
Conclusions |
This study supports using the GOS for ophthalmic procedures such as MIGS. Further evaluation of the GOS in different patient subgroups and clinical settings is needed.
Le texte complet de cet article est disponible en PDF.Plan
| Supplemental Material available at AJO.com. |
|
| Glaucoma Outcomes Survey Collaborative Study Group: Don Nguyen, Robert M. Saltzmann, Oluwatosin Smith, My Le Shaw, Lisa Rosenberg, Leo Seibold, Savak Teymoorian, Lorraine M. Provencher, Amanda K. Bicket, Nitika Arora, Anna K. Junk, Craig Chaya, Sarwat Salim, Debbie Kuo, Asher Weiner, Ze Zhang, Brian Francis Douglas Rhee, Brian McMillan, Clara Choo, Winston Garris, Rob Noecker, Ronald Fellman, Joseph Caprioli, Steven Vold, Louis Pasquale, Qi Cui, Michael Mbagwu. |
Vol 266
P. 313-320 - octobre 2024 Retour au numéro
Article précédent
- The Effect of High-Dose Erythropoietin Perinatally on Retinal Function in School-Aged Children Born Extremely or Very Preterm
- Lorena Sisera, James V.M. Hanson, Jonas Füglistaler, Brida M. Jeltsch, Sarah Patzelt, Flavia M. Wehrle, Cornelia F. Hagmann, Jean-Claude Fauchère, Rachel Heyard, Christina Gerth-Kahlert
- Comment on: Predicting Glaucoma Before Onset Using a Large Language Model Chatbot
- Shuo Wang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?